Novel 1,3,5-triazine-based pyrazole derivatives as potential antitumor agents and EFGR kinase inhibitors: synthesis, cytotoxicity, DNA binding, molecular docking and DFT studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel 1,3,5-triazine-based pyrazole derivatives as potential antitumor agents and EFGR kinase inhibitors: synthesis, cytotoxicity, DNA binding, molecular docking and DFT studies

Published:2021 Issue:31 Volume:45 Page:13909-13924
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Raghu M. S.¹²³,Pradeep Kumar C. B.⁴⁵³,Prashanth M. K.⁶⁷³^ORCID,Yogesh Kumar K.⁸⁹³,Prathibha B. S.⁶⁷³,Kanthimathi G.¹⁰¹¹³,Alissa Siham Abdulrahman¹²¹³¹⁴,Alghulikah Hanan Abdulrahman¹²¹³¹⁴,Osman Sameh M.¹⁵¹⁶¹⁴

Affiliation:

1. Department of Chemistry, New Horizon College of Engineering

2. Bengaluru 560 103

3. India

4. Department of Chemistry, Malnad College of Engineering

5. Hassan 573 202

6. Department of Chemistry, B N M Institute of Technology

7. Bengaluru 560 070

8. Department of Chemistry, School of Engineering and Technology, Jain University

9. Ramanagara

10. Department of Chemistry, Ramco Institute of Technology

11. Rajapalayam

12. Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University

13. Riyadh 11671

14. Saudi Arabia

15. Department of Chemistry, College of Science, King Saud University

16. Riyadh

Abstract

The development of new 1,3,5-triazine-based pyrazole derivatives as effective anticancer agents.

Funder

Princess Nourah Bint Abdulrahman University

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2021/NJ/D1NJ02419A

Reference44 articles.

1. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention

2. Molecular targeted therapy of cancer: The progress and future prospect

3. Synthesis, SAR and pharmacological characterization of novel anthraquinone cation compounds as potential anticancer agents

4. New Potential Antitumor Pyrazole Derivatives: Synthesis and Cytotoxic Evaluation

5. Recently reported biological activities of pyrazole compounds

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1,3,5-Triazine as a promising scaffold in the development of therapeutic agents against breast cancer;European Journal of Medicinal Chemistry;2024-10

2. Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR‐Targeted Anticancer Agents;Chemistry & Biodiversity;2024-09-11

3. Synthesis, Anticancer Activity, and Docking Studies of Novel Hydroquinone-Chalcone-Pyrazoline Hybrid Derivatives;International Journal of Molecular Sciences;2024-07-02

4. Enhancing Virtual Power Plant Dynamics with Renewable Energy and Storage for Improved Distributed Generation;2024 International Conference on Communication, Computer Sciences and Engineering (IC3SE);2024-05-09

5. Advancing Power System Evolution with the Energy Internet for Renewable Integration and Grid Optimization;2024 International Conference on Communication, Computer Sciences and Engineering (IC3SE);2024-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3